CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis

Published:2017-12-19 Issue:2 Volume:30 Page:229-240
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Xi Ziwei¹,Fang Fang²,Wang Jiayang¹,AlHelal Jumana³,Zhou Yujie¹,Liu Wei¹^ORCID

Affiliation:

1. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China

2. Sleep Center, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China

3. International School of Capital Medical University, Beijing, China

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2017.1413178

Reference53 articles.

1. Clinical evidence for oral antiplatelet therapy in acute coronary syndromes

2. Prevalence of poor biological response to clopidogrel

3. Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite